Drug record
What four public record sets show for amlodipine. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.010 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $332.3 million | Details |
| FDA recall records | 98 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Amlodipine Besylate 5 Mg Tab: pharmacies pay about $0.010 each, or $0.304 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| AMLODIPINE BESYLATE 10 MG TAB | Generic | $0.014 per each | $0.432 | Oct 21, 2026 |
| AMLODIPINE BESYLATE 2.5 MG TAB | Generic | $0.011 per each | $0.332 | Oct 21, 2026 |
| AMLODIPINE BESYLATE 5 MG TAB | Generic | $0.010 per each | $0.304 | Oct 21, 2026 |
| KATERZIA 1 MG/ML SUSPENSION | Brand | $4.21 per mL | — | Oct 21, 2026 |
| NORLIQVA 1 MG/ML SOLUTION | Brand | $3.21 per mL | — | Oct 21, 2026 |
| NORVASC 10 MG TABLET | Brand | $11.92 per each | $357.71 | Oct 21, 2026 |
| NORVASC 2.5 MG TABLET | Brand | $8.70 per each | $261.11 | Jan 1, 2026 |
| NORVASC 5 MG TABLET | Brand | $8.69 per each | $260.85 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $332.3 million for the 4 products below. That is up 0% from $331.5 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Amlodipine Besylate Amlodipine Besylate | $315.7 million | 12,195,951 | $6.29 | $25.88 | $306.8 million |
| Norvasc Amlodipine Besylate | $14.5 million | 5,263 | $696.96 | $2,747.32 | $23.7 million |
| Katerzia Amlodipine Benzoate | $1.5 million | 375 | $879.62 | $4,022.79 | $1.0 million |
| Norliqva Amlodipine Besylate | $636,093 | 238 | $760.88 | $2,672.66 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Amlodipine Besylate-Benazepril, Amlodipine-Atorvastatin, Amlodipine-Olmesartan, Amlodipine-Valsartan, Amlodipine-Valsartan-HCTZ, Azor, Caduet, Exforge, Exforge HCT, Lotrel, Telmisartan-Amlodipine.
Recalls reported to the FDA that name this drug.
The FDA has 98 recall records that name amlodipine in the product description (77 Class II · 21 Class III). 35 are still marked ongoing.
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India
Reason: Failed Dissolution Specifications.
Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
Reason: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30.
Reason: Out of specification due to dissolution.
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
Reason: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
Reason: Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30
Reason: Failed Dissolution Specifications: low dissolution results
Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.
Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03
Reason: Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07.
Reason: cGMP deviations
Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx Only NDC 33342-192-07 Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2180-30.
Reason: Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30.
Reason: Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for amlodipine. This page is public-record information, not medical advice.